$DRIO
DarioHealth Corp.

2014 Q4 Form 10-Q Financial Statement

#000114420414068170 Filed on November 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $50.00K $0.00 $0.00
YoY Change
Cost Of Revenue $660.0K $585.0K
YoY Change
Gross Profit -$610.0K -$585.0K
YoY Change
Gross Profit Margin -1220.0%
Selling, General & Admin $750.0K $1.150M $1.910M
YoY Change -60.73% -46.76% 189.39%
% of Gross Profit
Research & Development $730.0K $769.0K $1.740M
YoY Change -58.05% -28.66%
% of Gross Profit
Depreciation & Amortization $90.00K $100.0K $260.0K
YoY Change -65.38% -62.96% 2500.0%
% of Gross Profit
Operating Expenses $1.480M $1.922M $3.650M
YoY Change -59.45% -40.64% 129.56%
Operating Profit -$2.090M -$2.507M
YoY Change -22.58%
Interest Expense -$970.0K $2.600M $3.710M
YoY Change -126.15% -1230.43% 1136.67%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$570.0K
YoY Change 144.64%
Pretax Income -$3.560M -$3.080M $50.00K
YoY Change -7220.0% -11.24% -104.2%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.560M -$3.077M $50.00K
YoY Change -7220.0% -11.35% -104.2%
Net Earnings / Revenue -7120.0%
Basic Earnings Per Share -$0.66
Diluted Earnings Per Share -$89.00M -$0.66 $5.000M
COMMON SHARES
Basic Shares Outstanding 16.23M shares 9.610M shares 20.07M shares
Diluted Shares Outstanding 9.610M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.500M $4.300M $2.400M
YoY Change -37.5% -6.52% 84.62%
Cash & Equivalents $1.453M $4.170M $2.263M
Short-Term Investments $100.0K $100.0K $200.0K
Other Short-Term Assets $33.00K $0.00 $52.00K
YoY Change -36.54% -27.2%
Inventory $234.0K $109.0K $0.00
Prepaid Expenses
Receivables $94.00K $0.00
Other Receivables
Total Short-Term Assets $2.056M $4.728M $2.930M
YoY Change -29.83% -8.42% 75.81%
LONG-TERM ASSETS
Property, Plant & Equipment $978.0K $1.226M $1.145M
YoY Change -14.59% -10.65% 85.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $1.025M $1.274M $1.186M
YoY Change -13.58% -14.71% 82.77%
TOTAL ASSETS
Total Short-Term Assets $2.056M $4.728M $2.930M
Total Long-Term Assets $1.025M $1.274M $1.186M
Total Assets $3.081M $6.002M $4.116M
YoY Change -25.15% -9.83% 77.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $1.300M $600.0K
YoY Change 16.67% 116.67% 100.0%
Accrued Expenses $679.0K $591.0K
YoY Change 14.89% 154.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.616M $2.094M $1.506M
YoY Change 7.3% 92.36% 165.72%
LONG-TERM LIABILITIES
Long-Term Debt $2.800M $5.800M $0.00
YoY Change
Other Long-Term Liabilities $4.000M $3.100M $2.700M
YoY Change 48.15% -51.56% -3.57%
Total Long-Term Liabilities $6.800M $8.900M $2.700M
YoY Change 151.85% 39.06% -3.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.616M $2.094M $1.506M
Total Long-Term Liabilities $6.800M $8.900M $2.700M
Total Liabilities $8.400M $10.90M $4.200M
YoY Change 100.0% 45.33% 23.53%
SHAREHOLDERS EQUITY
Retained Earnings -$36.06M -$32.57M -$20.00M
YoY Change 80.26%
Common Stock $2.000K $2.000K $0.00
YoY Change 0.05% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.295M -$4.926M -$86.00K
YoY Change
Total Liabilities & Shareholders Equity $3.081M $6.002M $4.116M
YoY Change -25.15% -9.83% 77.76%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income -$3.560M -$3.077M $50.00K
YoY Change -7220.0% -11.35% -104.2%
Depreciation, Depletion And Amortization $90.00K $100.0K $260.0K
YoY Change -65.38% -62.96% 2500.0%
Cash From Operating Activities -$2.410M -$1.750M -$2.130M
YoY Change 13.15% -28.57% 45.89%
INVESTING ACTIVITIES
Capital Expenditures -$340.0K -$70.00K -$90.00K
YoY Change 277.78% -56.25% -82.0%
Acquisitions
YoY Change
Other Investing Activities $40.00K $70.00K -$60.00K
YoY Change -166.67% 500.0%
Cash From Investing Activities -$300.0K $0.00 -$160.0K
YoY Change 87.5% -100.0% -68.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.100M 70.00K
YoY Change -100.0% 8100.0% -97.07%
NET CHANGE
Cash From Operating Activities -2.410M -1.750M -2.130M
Cash From Investing Activities -300.0K 0.000 -160.0K
Cash From Financing Activities 0.000 4.100M 70.00K
Net Change In Cash -2.710M 2.350M -2.220M
YoY Change 22.07% -192.16% -628.57%
FREE CASH FLOW
Cash From Operating Activities -$2.410M -$1.750M -$2.130M
Capital Expenditures -$340.0K -$70.00K -$90.00K
Free Cash Flow -$2.070M -$1.680M -$2.040M
YoY Change 1.47% -26.64% 112.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>NOTE 3:-</div> </td> <td style="TEXT-ALIGN: justify"> <div>UNAUDITED INTERIM FINANCIAL STATEMENTS</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying unaudited interim consolidated financial statements as of September 30, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of September 30, 2014, the Company's consolidated results of operations and the Company's consolidated cash flows for the nine and three months ended September 30, 2014. Results for the nine and three months periods ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4170000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2263000 USD
CY2014Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
0 USD
CY2013Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
38000 USD
CY2014Q3 us-gaap Short Term Investments
ShortTermInvestments
87000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
154000 USD
CY2014Q3 drio Other Accounts Receivable And Prepaid Expenses
OtherAccountsReceivableAndPrepaidExpenses
362000 USD
CY2013Q4 drio Other Accounts Receivable And Prepaid Expenses
OtherAccountsReceivableAndPrepaidExpenses
475000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
109000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
4728000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2930000 USD
CY2014Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
48000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1226000 USD
CY2014Q3 us-gaap Assets
Assets
6002000 USD
CY2014Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1276000 USD
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
586000 USD
CY2014Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
818000 USD
CY2013Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
920000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2094000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1506000 USD
CY2014Q3 drio Liability Related To Warrants
LiabilityRelatedToWarrants
3053000 USD
CY2013Q4 drio Liability Related To Warrants
LiabilityRelatedToWarrants
2696000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27646000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
-4926000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-86000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6002000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4116000 USD
CY2013Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
41000 USD
CY2013Q4 us-gaap Assets
Assets
4116000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1145000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19917000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-13931000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15905871 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4014381 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15905871 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4014381 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4940000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6168000 USD
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q3 us-gaap Revenues
Revenues
0 USD
CY2014Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
1611000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
585000 USD
us-gaap Gross Profit
GrossProfit
-1611000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
0 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
-585000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3169000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3209000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1078000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
769000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1924000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
911000 USD
CY2013Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
763000 USD
CY2014Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
252000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4817000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3047000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1397000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
901000 USD
us-gaap Operating Expenses
OperatingExpenses
9910000 USD
us-gaap Operating Expenses
OperatingExpenses
7167000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3238000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
1922000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9910000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3238000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2507000 USD
drio Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
-3992000 USD
drio Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
3144000 USD
CY2013Q3 drio Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
-192000 USD
CY2014Q3 drio Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
2606000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-83000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3681000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3176000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4075000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-537000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-233000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-570000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13985000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3471000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3077000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.03
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3551559 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6179981 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3994481 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9610160 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3551559 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6194418 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3994481 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9610160 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-1070000 USD
CY2013 drio Stock Issued During Period Value New Issues February And June2013
StockIssuedDuringPeriodValueNewIssuesFebruaryAndJune2013
996000 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
488000 USD
CY2013 drio Warrant Issued During Period For Services Value March And May2013
WarrantIssuedDuringPeriodForServicesValueMarchAndMay2013
523000 USD
CY2013 drio Stock Issued During Period Value New Issues April And May2013
StockIssuedDuringPeriodValueNewIssuesAprilAndMay2013
8987000 USD
drio Stock Issued During Period Value New Issues February2014
StockIssuedDuringPeriodValueNewIssuesFebruary2014
1013000 USD
CY2013 drio Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
708000 USD
drio Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
352000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3213000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1522000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1522000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
323000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
894000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P9M
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
343000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
754000 USD
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
374000 USD
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
194000 USD
CY2013Q3 drio Legal And Professional Fees
LegalAndProfessionalFees
423000 USD
CY2014Q3 drio Legal And Professional Fees
LegalAndProfessionalFees
335000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1927000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1128000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
569000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
251000 USD
drio Stock And Warrants Issued During Period To Service Provider
StockAndWarrantsIssuedDuringPeriodToServiceProvider
1011000 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
LabStyle Innovations Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001533998
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
drio Stock And Warrants Issued During Period To Service Provider
StockAndWarrantsIssuedDuringPeriodToServiceProvider
0 USD
CY2013Q3 drio Stock And Warrants Issued During Period To Service Provider
StockAndWarrantsIssuedDuringPeriodToServiceProvider
0 USD
CY2014Q3 drio Stock And Warrants Issued During Period To Service Provider
StockAndWarrantsIssuedDuringPeriodToServiceProvider
0 USD
us-gaap Other Expenses
OtherExpenses
79000 USD
us-gaap Other Expenses
OtherExpenses
377000 USD
CY2013Q3 us-gaap Other Expenses
OtherExpenses
31000 USD
CY2014Q3 us-gaap Other Expenses
OtherExpenses
121000 USD
drio Bank Charges
BankCharges
19000 USD
drio Bank Charges
BankCharges
13000 USD
CY2013Q3 drio Bank Charges
BankCharges
5000 USD
CY2014Q3 drio Bank Charges
BankCharges
6000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-64000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000 USD
CY2013Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-36000 USD
CY2014Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
533000 USD
CY2013Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2014Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
44000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13985000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12571000 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3471000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6333000 USD
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 USD
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-1236000 USD
CY2013Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 USD
CY2014Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-13985000 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-13807000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-3471000 USD
CY2014Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-6333000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
14437 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
drio Stockbased Compensation Warrants And Restricted Shares
StockbasedCompensationWarrantsAndRestrictedShares
3605000 USD
drio Stockbased Compensation Warrants And Restricted Shares
StockbasedCompensationWarrantsAndRestrictedShares
1522000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
533000 USD
us-gaap Depreciation
Depreciation
578000 USD
us-gaap Depreciation
Depreciation
461000 USD
drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
156000 USD
drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
-117000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
109000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
275000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
367000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
217000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
276000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5474000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
105000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
130000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
35000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
230000 USD
us-gaap Payments To Acquire Leases Held For Investment
PaymentsToAcquireLeasesHeldForInvestment
106000 USD
us-gaap Payments To Acquire Leases Held For Investment
PaymentsToAcquireLeasesHeldForInvestment
6000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1308000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
219000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1484000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-125000 USD
drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
9970000 USD
drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
3754000 USD
drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
226000 USD
drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
350000 USD
drio Stock Issued During Period Value Upon Reset Price Mechanism
StockIssuedDuringPeriodValueUponResetPriceMechanism
USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10196000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8200000 USD
drio Deemed Dividend Related To Exchange Agreement Adjustment
DeemedDividendRelatedToExchangeAgreementAdjustment
0 USD
drio Stock Issued During Period Value Upon Exchange Agreement
StockIssuedDuringPeriodValueUponExchangeAgreement
4558000 USD
drio Deemed Dividend Related To Preferred Stock
DeemedDividendRelatedToPreferredStock
-2977000 USD
CY2014Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5781000 USD
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3238000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1907000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1230000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4468000 USD
drio Receivable On Account Of Shares
ReceivableOnAccountOfShares
12000 USD
drio Receivable On Account Of Shares
ReceivableOnAccountOfShares
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
29000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
323000 USD
drio Conversionofwarantliabilitytocommonstock
Conversionofwarantliabilitytocommonstock
403000 USD
drio Conversionofwarantliabilitytocommonstock
Conversionofwarantliabilitytocommonstock
9000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32574000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20003000 USD
drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
0 USD
drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
279000 USD
CY2013Q3 drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
0 USD
CY2014Q3 drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
279000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2977000 USD
CY2013Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2977000 USD
drio Proceeds From Issuance Of Preferred Stock And Warrants
ProceedsFromIssuanceOfPreferredStockAndWarrants
0 USD
drio Proceeds From Issuance Of Preferred Stock And Warrants
ProceedsFromIssuanceOfPreferredStockAndWarrants
4096000 USD
drio Compensation To Investors From Exchange Agreement
CompensationToInvestorsFromExchangeAgreement
0 USD
drio Compensation To Investors From Exchange Agreement
CompensationToInvestorsFromExchangeAgreement
3124000 USD
dei Document Type
DocumentType
10-Q
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
DRIO
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16233430 shares
CY2013Q3 drio Compensation To Investors From Exchange Agreement
CompensationToInvestorsFromExchangeAgreement
0 USD
CY2014Q3 drio Compensation To Investors From Exchange Agreement
CompensationToInvestorsFromExchangeAgreement
3124000 USD
CY2014Q3 drio Preferred Stock Converted Into Common Stock At Ratio
PreferredStockConvertedIntoCommonStockAtRatio
ratio of 1 to 252

Files In Submission

Name View Source Status
0001144204-14-068170-index-headers.html Edgar Link pending
0001144204-14-068170-index.html Edgar Link pending
0001144204-14-068170.txt Edgar Link pending
0001144204-14-068170-xbrl.zip Edgar Link pending
drio-20140930.xml Edgar Link completed
drio-20140930.xsd Edgar Link pending
drio-20140930_cal.xml Edgar Link unprocessable
drio-20140930_def.xml Edgar Link unprocessable
drio-20140930_lab.xml Edgar Link unprocessable
drio-20140930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v392947_10q.htm Edgar Link pending
v392947_ex31-1.htm Edgar Link pending
v392947_ex31-2.htm Edgar Link pending
v392947_ex32-1.htm Edgar Link pending
v392947_ex32-2.htm Edgar Link pending